Global Recombinant Human Follitropin Market Growth (Status and Outlook) 2025-2031

December 2025 | 100 pages | ID: G879C41470A9EN
LP Information

Abstracts

According to this study, the global Recombinant Human Follitropin market size will reach US$ 2072 million by 2031.

Follitropin is a form of recombinant human follicle stimulating hormone used to stimulate follicle development in women with primary ovarian hypogonadism and in men with hypogonadotropic hypogonadism.

Infertility affects many people at some point in their lives, according to a new report from the World Health Organization (WHO) released in 2023. About 17.5% of adults (about one in six people worldwide) experience infertility, highlighting the urgent need to expand access to affordable, high-quality reproductive health care for those who need it. Recombinant human follitropin is used in the treatment of female infertility and male hypogonadism. The safety and effectiveness of recombinant human follitropin have been verified in a large number of clinical applications. In the future, as biosimilar technology continues to mature and costs decrease, generic drugs will gradually break the market monopoly of original drugs and improve the accessibility of treatment. Generic drug companies will further enhance their market competitiveness by optimizing production processes, improving product quality and developing long-acting preparations.

LPI (LP Information)' newest research report, the “Recombinant Human Follitropin Industry Forecast” looks at past sales and reviews total world Recombinant Human Follitropin sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Human Follitropin sales for 2025 through 2031. With Recombinant Human Follitropin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Follitropin industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Human Follitropin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Human Follitropin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Follitropin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Follitropin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Follitropin.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Follitropin market by product type, application, key players and key regions and countries.

Segmentation by Type:

• 75IU
• 150IU
• 300IU
• Others

Segmentation by Application:

• Women
• Men

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck KGaA
• Organon
• Gedeon Richter
• Ferring
• Changchun High-Tech
• Theramex
• Qilu Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Human Follitropin Market Size (2020-2031)
  2.1.2 Recombinant Human Follitropin Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Recombinant Human Follitropin by Country/Region (2020, 2024 & 2031)
2.2 Recombinant Human Follitropin Segment by Type
  2.2.1 75IU
  2.2.2 150IU
  2.2.3 300IU
  2.2.4 Others
2.3 Recombinant Human Follitropin Market Size by Type
  2.3.1 Recombinant Human Follitropin Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Recombinant Human Follitropin Market Size Market Share by Type (2020-2025)
2.4 Recombinant Human Follitropin Segment by Application
  2.4.1 Women
  2.4.2 Men
2.5 Recombinant Human Follitropin Market Size by Application
  2.5.1 Recombinant Human Follitropin Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Recombinant Human Follitropin Market Size Market Share by Application (2020-2025)

3 RECOMBINANT HUMAN FOLLITROPIN MARKET SIZE BY PLAYER

3.1 Recombinant Human Follitropin Market Size Market Share by Player
  3.1.1 Global Recombinant Human Follitropin Revenue by Player (2020-2025)
  3.1.2 Global Recombinant Human Follitropin Revenue Market Share by Player (2020-2025)
3.2 Global Recombinant Human Follitropin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECOMBINANT HUMAN FOLLITROPIN BY REGION

4.1 Recombinant Human Follitropin Market Size by Region (2020-2025)
4.2 Global Recombinant Human Follitropin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Human Follitropin Market Size Growth (2020-2025)
4.4 APAC Recombinant Human Follitropin Market Size Growth (2020-2025)
4.5 Europe Recombinant Human Follitropin Market Size Growth (2020-2025)
4.6 Middle East & Africa Recombinant Human Follitropin Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Recombinant Human Follitropin Market Size by Country (2020-2025)
5.2 Americas Recombinant Human Follitropin Market Size by Type (2020-2025)
5.3 Americas Recombinant Human Follitropin Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Recombinant Human Follitropin Market Size by Region (2020-2025)
6.2 APAC Recombinant Human Follitropin Market Size by Type (2020-2025)
6.3 APAC Recombinant Human Follitropin Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Recombinant Human Follitropin Market Size by Country (2020-2025)
7.2 Europe Recombinant Human Follitropin Market Size by Type (2020-2025)
7.3 Europe Recombinant Human Follitropin Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Human Follitropin by Region (2020-2025)
8.2 Middle East & Africa Recombinant Human Follitropin Market Size by Type (2020-2025)
8.3 Middle East & Africa Recombinant Human Follitropin Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RECOMBINANT HUMAN FOLLITROPIN MARKET FORECAST

10.1 Global Recombinant Human Follitropin Forecast by Region (2026-2031)
  10.1.1 Global Recombinant Human Follitropin Forecast by Region (2026-2031)
  10.1.2 Americas Recombinant Human Follitropin Forecast
  10.1.3 APAC Recombinant Human Follitropin Forecast
  10.1.4 Europe Recombinant Human Follitropin Forecast
  10.1.5 Middle East & Africa Recombinant Human Follitropin Forecast
10.2 Americas Recombinant Human Follitropin Forecast by Country (2026-2031)
  10.2.1 United States Market Recombinant Human Follitropin Forecast
  10.2.2 Canada Market Recombinant Human Follitropin Forecast
  10.2.3 Mexico Market Recombinant Human Follitropin Forecast
  10.2.4 Brazil Market Recombinant Human Follitropin Forecast
10.3 APAC Recombinant Human Follitropin Forecast by Region (2026-2031)
  10.3.1 China Recombinant Human Follitropin Market Forecast
  10.3.2 Japan Market Recombinant Human Follitropin Forecast
  10.3.3 Korea Market Recombinant Human Follitropin Forecast
  10.3.4 Southeast Asia Market Recombinant Human Follitropin Forecast
  10.3.5 India Market Recombinant Human Follitropin Forecast
  10.3.6 Australia Market Recombinant Human Follitropin Forecast
10.4 Europe Recombinant Human Follitropin Forecast by Country (2026-2031)
  10.4.1 Germany Market Recombinant Human Follitropin Forecast
  10.4.2 France Market Recombinant Human Follitropin Forecast
  10.4.3 UK Market Recombinant Human Follitropin Forecast
  10.4.4 Italy Market Recombinant Human Follitropin Forecast
  10.4.5 Russia Market Recombinant Human Follitropin Forecast
10.5 Middle East & Africa Recombinant Human Follitropin Forecast by Region (2026-2031)
  10.5.1 Egypt Market Recombinant Human Follitropin Forecast
  10.5.2 South Africa Market Recombinant Human Follitropin Forecast
  10.5.3 Israel Market Recombinant Human Follitropin Forecast
  10.5.4 Turkey Market Recombinant Human Follitropin Forecast
10.6 Global Recombinant Human Follitropin Forecast by Type (2026-2031)
10.7 Global Recombinant Human Follitropin Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Recombinant Human Follitropin Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck KGaA
  11.1.1 Merck KGaA Company Information
  11.1.2 Merck KGaA Recombinant Human Follitropin Product Offered
  11.1.3 Merck KGaA Recombinant Human Follitropin Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Merck KGaA Main Business Overview
  11.1.5 Merck KGaA Latest Developments
11.2 Organon
  11.2.1 Organon Company Information
  11.2.2 Organon Recombinant Human Follitropin Product Offered
  11.2.3 Organon Recombinant Human Follitropin Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Organon Main Business Overview
  11.2.5 Organon Latest Developments
11.3 Gedeon Richter
  11.3.1 Gedeon Richter Company Information
  11.3.2 Gedeon Richter Recombinant Human Follitropin Product Offered
  11.3.3 Gedeon Richter Recombinant Human Follitropin Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Gedeon Richter Main Business Overview
  11.3.5 Gedeon Richter Latest Developments
11.4 Ferring
  11.4.1 Ferring Company Information
  11.4.2 Ferring Recombinant Human Follitropin Product Offered
  11.4.3 Ferring Recombinant Human Follitropin Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Ferring Main Business Overview
  11.4.5 Ferring Latest Developments
11.5 Changchun High-Tech
  11.5.1 Changchun High-Tech Company Information
  11.5.2 Changchun High-Tech Recombinant Human Follitropin Product Offered
  11.5.3 Changchun High-Tech Recombinant Human Follitropin Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Changchun High-Tech Main Business Overview
  11.5.5 Changchun High-Tech Latest Developments
11.6 Theramex
  11.6.1 Theramex Company Information
  11.6.2 Theramex Recombinant Human Follitropin Product Offered
  11.6.3 Theramex Recombinant Human Follitropin Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Theramex Main Business Overview
  11.6.5 Theramex Latest Developments
11.7 Qilu Pharmaceutical
  11.7.1 Qilu Pharmaceutical Company Information
  11.7.2 Qilu Pharmaceutical Recombinant Human Follitropin Product Offered
  11.7.3 Qilu Pharmaceutical Recombinant Human Follitropin Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Qilu Pharmaceutical Main Business Overview
  11.7.5 Qilu Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Recombinant Human Follitropin Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Recombinant Human Follitropin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 75IU
Table 4. Major Players of 150IU
Table 5. Major Players of 300IU
Table 6. Major Players of Others
Table 7. Recombinant Human Follitropin Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Recombinant Human Follitropin Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Recombinant Human Follitropin Market Size Market Share by Type (2020-2025)
Table 10. Recombinant Human Follitropin Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Recombinant Human Follitropin Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Recombinant Human Follitropin Market Size Market Share by Application (2020-2025)
Table 13. Global Recombinant Human Follitropin Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Recombinant Human Follitropin Revenue Market Share by Player (2020-2025)
Table 15. Recombinant Human Follitropin Key Players Head office and Products Offered
Table 16. Recombinant Human Follitropin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Recombinant Human Follitropin Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Recombinant Human Follitropin Market Size Market Share by Region (2020-2025)
Table 21. Global Recombinant Human Follitropin Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Recombinant Human Follitropin Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Recombinant Human Follitropin Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Recombinant Human Follitropin Market Size Market Share by Country (2020-2025)
Table 25. Americas Recombinant Human Follitropin Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Recombinant Human Follitropin Market Size Market Share by Type (2020-2025)
Table 27. Americas Recombinant Human Follitropin Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Recombinant Human Follitropin Market Size Market Share by Application (2020-2025)
Table 29. APAC Recombinant Human Follitropin Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Recombinant Human Follitropin Market Size Market Share by Region (2020-2025)
Table 31. APAC Recombinant Human Follitropin Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Recombinant Human Follitropin Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Recombinant Human Follitropin Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Recombinant Human Follitropin Market Size Market Share by Country (2020-2025)
Table 35. Europe Recombinant Human Follitropin Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Recombinant Human Follitropin Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Recombinant Human Follitropin Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Recombinant Human Follitropin Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Recombinant Human Follitropin Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Recombinant Human Follitropin
Table 41. Key Market Challenges & Risks of Recombinant Human Follitropin
Table 42. Key Industry Trends of Recombinant Human Follitropin
Table 43. Global Recombinant Human Follitropin Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Recombinant Human Follitropin Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Recombinant Human Follitropin Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Recombinant Human Follitropin Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Merck KGaA Details, Company Type, Recombinant Human Follitropin Area Served and Its Competitors
Table 48. Merck KGaA Recombinant Human Follitropin Product Offered
Table 49. Merck KGaA Recombinant Human Follitropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Merck KGaA Main Business
Table 51. Merck KGaA Latest Developments
Table 52. Organon Details, Company Type, Recombinant Human Follitropin Area Served and Its Competitors
Table 53. Organon Recombinant Human Follitropin Product Offered
Table 54. Organon Recombinant Human Follitropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Organon Main Business
Table 56. Organon Latest Developments
Table 57. Gedeon Richter Details, Company Type, Recombinant Human Follitropin Area Served and Its Competitors
Table 58. Gedeon Richter Recombinant Human Follitropin Product Offered
Table 59. Gedeon Richter Recombinant Human Follitropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Gedeon Richter Main Business
Table 61. Gedeon Richter Latest Developments
Table 62. Ferring Details, Company Type, Recombinant Human Follitropin Area Served and Its Competitors
Table 63. Ferring Recombinant Human Follitropin Product Offered
Table 64. Ferring Recombinant Human Follitropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Ferring Main Business
Table 66. Ferring Latest Developments
Table 67. Changchun High-Tech Details, Company Type, Recombinant Human Follitropin Area Served and Its Competitors
Table 68. Changchun High-Tech Recombinant Human Follitropin Product Offered
Table 69. Changchun High-Tech Recombinant Human Follitropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Changchun High-Tech Main Business
Table 71. Changchun High-Tech Latest Developments
Table 72. Theramex Details, Company Type, Recombinant Human Follitropin Area Served and Its Competitors
Table 73. Theramex Recombinant Human Follitropin Product Offered
Table 74. Theramex Recombinant Human Follitropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Theramex Main Business
Table 76. Theramex Latest Developments
Table 77. Qilu Pharmaceutical Details, Company Type, Recombinant Human Follitropin Area Served and Its Competitors
Table 78. Qilu Pharmaceutical Recombinant Human Follitropin Product Offered
Table 79. Qilu Pharmaceutical Recombinant Human Follitropin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Qilu Pharmaceutical Main Business
Table 81. Qilu Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Human Follitropin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Human Follitropin Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Recombinant Human Follitropin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Recombinant Human Follitropin Sales Market Share by Country/Region (2024)
Figure 8. Recombinant Human Follitropin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Recombinant Human Follitropin Market Size Market Share by Type in 2024
Figure 10. Recombinant Human Follitropin in Women
Figure 11. Global Recombinant Human Follitropin Market: Women (2020-2025) & ($ millions)
Figure 12. Recombinant Human Follitropin in Men
Figure 13. Global Recombinant Human Follitropin Market: Men (2020-2025) & ($ millions)
Figure 14. Global Recombinant Human Follitropin Market Size Market Share by Application in 2024
Figure 15. Global Recombinant Human Follitropin Revenue Market Share by Player in 2024
Figure 16. Global Recombinant Human Follitropin Market Size Market Share by Region (2020-2025)
Figure 17. Americas Recombinant Human Follitropin Market Size 2020-2025 ($ millions)
Figure 18. APAC Recombinant Human Follitropin Market Size 2020-2025 ($ millions)
Figure 19. Europe Recombinant Human Follitropin Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Recombinant Human Follitropin Market Size 2020-2025 ($ millions)
Figure 21. Americas Recombinant Human Follitropin Value Market Share by Country in 2024
Figure 22. United States Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Recombinant Human Follitropin Market Size Market Share by Region in 2024
Figure 27. APAC Recombinant Human Follitropin Market Size Market Share by Type (2020-2025)
Figure 28. APAC Recombinant Human Follitropin Market Size Market Share by Application (2020-2025)
Figure 29. China Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 33. India Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Recombinant Human Follitropin Market Size Market Share by Country in 2024
Figure 36. Europe Recombinant Human Follitropin Market Size Market Share by Type (2020-2025)
Figure 37. Europe Recombinant Human Follitropin Market Size Market Share by Application (2020-2025)
Figure 38. Germany Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 39. France Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Recombinant Human Follitropin Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Recombinant Human Follitropin Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Recombinant Human Follitropin Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Recombinant Human Follitropin Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 52. APAC Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 53. Europe Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 55. United States Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 56. Canada Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 57. Mexico Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 58. Brazil Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 59. China Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 60. Japan Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 61. Korea Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 63. India Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 64. Australia Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 65. Germany Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 66. France Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 67. UK Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 68. Italy Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 69. Russia Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 70. Egypt Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 71. South Africa Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 72. Israel Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 73. Turkey Recombinant Human Follitropin Market Size 2026-2031 ($ millions)
Figure 74. Global Recombinant Human Follitropin Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Recombinant Human Follitropin Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Recombinant Human Follitropin Market Size 2026-2031 ($ millions)